Data

Click on Protocol Number of interest to view study-related documentation or download data files. (DTMC data files are under development.)
Division Study Number Title Investigator(s) Release Date
DTMC NIDA-CTO-0003 Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone Thomas F. Newton, M.D. Aug 01, 2016
DTMC NIDA-CTO-0004 Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline Thomas F. Newton, M.D. Aug 01, 2016
DTMC NIDA-CTO-0005 Double-Blind, Placebo-Controlled Trial Of Ondansetron For The Treatment Of Cocaine Dependence John D. Roache, Ph.D. Aug 01, 2016
DTMC NIDA-CTO-0006 Cocaine-Metyrapone Interaction Study Bonita Singal, M.D., T. John Winhusen, Ph.D. Aug 01, 2016
DTMC NIDA-CTO-0007 Phase 2, Double-Blind, Placebo-Controlled Trial Of Cabergoline For The Treatment Of Cocaine Dependence Steven Shoptaw, Ph.D., Thomas F. Newton, M.D. Dec 21, 2017
DTMC NIDA-CTO-0008 Phase 2, Double-Blind Placebo-Controlled Trial Of Bupropion for the Treatment of Methamphetamine Dependence Richard Rawson, Ph.D. May 07, 2018
DTMC NIDA-CTO-0010 Assessment of Potential Interactions Between Methamphetamine and Bupropion Thomas F. Newton, M.D. May 07, 2018
DTMC NIDA-CTO-0011 Double-Blind, Placebo-Controlled, Dose Response Trial Of Ondansetron For The Treatment Of Methamphetamine Dependence Bankole Johnson, DSc., M.D., Ph.D. Jan 15, 2019
DTMC NIDA-CTO-0012 Phase 2, Double-Blind, Placebo-Controlled Trial Of Tiagabine For The Treatment Of Cocaine Dependence Eugene Somoza, M.D. Jan 15, 2019
DTMC NIDA-MDS-0002 Assessment of Interactions Between Methamphetamine and Aripiprazole Thomas F. Newton, M.D. May 07, 2018